Search Within

Isabelle C Riviere

  1. "Terence Purdon"
  2. "Brigitte Senechal"
  3. "Center for Hematologic Malignancies"
  4. "Sloan Kettering Institute Postdocs"
  5. "Meeting abstract"
  6. "Jae Park"
Formats
  1. Meeting Abstract (4)
Groups
  1. Adult Leukemia (4)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. GSK Faculty (4)
  5. Hematologic Malignancies Research (4)
  6. Hematologic Malignancies, Division of (4)

More Groups

People
  1. Brigitte Senechal (4)
  2. Jae Park (4)
  3. Terence Purdon (4)
  4. Kevin Curran (3)
  5. Kinga Hosszu (3)
  6. Renier Brentjens (3)

More People

Years
  1. 2022 (1)
  2. 2021 (2)
  3. 2018 (1)
Publications
  1. Blood (2)
  2. Cytotherapy (2)
Publishers
  1. American Society of Hematology (2)
  2. Elsevier Science Ltd. (2)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Discovery proteomics for analytes to predict cytokine release syndrome on day of infusion of chimeric antigen receptor (CAR) T cells
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; Mcavoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Predictors for neurotoxicity on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save